Clinical Trials on Postcoital Bleeding in Switzerland

Total 58 results

University Hospital, Basel, Switzerland

Recruiting

Enhancement of the Haemostatic Effect of Platelets in the Presence of High Normal Concentrations of Von Willebrand Factor (Will-Plate)

Bleeding

Switzerland
Walid HABRE
University Hospital, Geneva

Terminated

Dexamethasone and Postoperative Bleeding Following Tonsillectomy in Children (Blueberry)

Pain, Postoperative | Postoperative Nausea and Vomiting | Tonsillar Bleeding

Canada, Switzerland
University Hospital, Geneva

Completed

DAPHNE Study: Direct Anticoagulant PHarmacogeNEtic (DAPHNE)

Anticoagulants and Bleeding Disorders

Switzerland
University of Zurich
Luzerner Kantonsspital; Cantonal Hospital of St. Gallen

Unknown

TXA in the EMS on the Helicopter and the Ambulance (TXASRZREGA)

Bleeding

Switzerland
University Hospital, Geneva

Recruiting

Bleeding of Unknown Cause: a Swiss Case-control Study (SWISS-BUC)

Bleeding Disorder

Switzerland
The Medicines Company

Terminated

Phase II Study to Compare MDCO-2010 vs Placebo and Tranexamic Acid in Patients Undergoing Cardiac Surgery

Bleeding

Germany, Switzerland
Centre Hospitalier Universitaire Vaudois

Completed

Prediction of Massive Transfusion in Trauma Patients (MTP)

Emergencies | Bleeding | Trauma Injury | Female | Blood Transfusion | Cohort Study | Prognosis | Adult | Male | Humans | Haemorrhagic Shock | Massive Transfusion | Massive Hemorrhage | Hospital Mortality | Bleeding Hemorrhage | Hemorrhage / Mortality | Models, Theoretical | Wounds and Injuries / Mortality

Switzerland
University of Bern
WALA Heilmittel GmbH

Completed

Clinical Trial for Evaluating Sage-Based Mouthrinse

Satisfaction | Stomatitis, Denture | Tooth Staining | Stomal Bleeding

Switzerland
Nestlé

Terminated

Placement of Novel Endoscopic Enteral Feeding Tube (LEGEND)

Healthy Volunteers | Enteral Feeding

Switzerland
University Hospital, Geneva

Completed

Standardisation of Investigations of Mild Bleeding Disorders (MBD)

Hemorrhagic Disorders

Switzerland
University Hospital, Basel, Switzerland

Completed

Rivaroxaban in Endovenous Laser Ablation With and Without Miniphlebectomy (RITE)

Venous Thrombosis | Bleeding | Varicose Veins | Thromboembolism

Switzerland
Centre Hospitalier Universitaire Vaudois

Recruiting

Optimization of Diet Before Surgery (OptiSurg) (OptiSurg)

Surgery | Time Restricted Feeding

Switzerland, United States
Clinica Luganese Moncucco
Ospedale Regionale Bellinzona e Valli

Completed

End-Tidal CO2 (etCO2) and pH in the Correct Naso-gastric Tube Placement (NGT)

pH | Blood Gas Monitoring, Transcutaneous | Gastric Feeding Tube

Switzerland
Novo Nordisk A/S

Completed

Efficacy and Safety of Activated Recombinant Human Factor VII in Treatment of Bleeding in Patients Following Allogeneic Stem Cell Transplantation

Acquired Bleeding Disorder | Bleeding During/Following Surgery

Israel, Sweden, United Kingdom, Germany, Switzerland, France, Spain, Italy, Thailand, Denmark, United States, Poland, Finland, Singapore, Australia, Austria
School of Health Sciences Geneva

Completed

Evaluation of Two Eating Disorders Prevention Interventions in At-Risk Female Students With Body Dissatisfaction (HEIDI-BP-HW)

Body Dissatisfaction

Switzerland
Philipp Gerber

Completed

Monitoring During Different Intermittent Fasting Protocols in Non-Obese Adults (LIMITFOOD)

Overweight | Time Restricted Feeding | Intermittent Fasting

Switzerland
University Hospital, Geneva
Danone Research

Completed

Influence of Protein Supplements on Serum Insulin-like Growth Factor-I Levels in Women With Anorexia Nervosa

Anorexia Nervosa

Switzerland
Gabriella Milos

Not yet recruiting

Metreleptin in Anorexia Nervosa (METRAN)

Anorexia Nervosa

Switzerland
Novo Nordisk A/S

Terminated

Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding (CONTROL)

Trauma | Acquired Bleeding Disorder

Spain, Hong Kong, Germany, France, United Kingdom, Brazil, Italy, Hungary, Netherlands, United States, Switzerland, Czech Republic, Greece, South Africa
Swiss Hemophilia Network

Recruiting

Swiss Hemophilia Registry

Hemophilia and Other Severe Bleeding Disorders

Switzerland
Psychiatric University Hospital, Zurich

Recruiting

Evaluation of the Effectiveness of Add-on Hometreatment to Family Based Therapy in Adolescent Anorexia Nervosa. (HTED)

Anorexia in Adolescence

Switzerland
Novo Nordisk A/S

Completed

Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects

Congenital Bleeding Disorder | Haemophilia A

Spain, Germany, Switzerland, Italy, Israel
University Hospital, Basel, Switzerland
University of Zurich

Recruiting

Novel Targetable BIOmarkers in ANorexia NervosA (BIOANNA)

Anorexia Nervosa | Anorexia Nervosa Restricting Type

Switzerland
Biosensors Europe SA
European Cardiovascular Research Center

Completed

Leaders Free III: BioFreedom™ Clinical Trial

Myocardial Infarction | Mortality | Bleeding | Cardiac Death | Stent Thrombosis

France, Switzerland
Kurt Hersberger

Terminated

Multidrug Blister Pack Study

Any Event Leading to Hospitalisation

Switzerland
University of Zurich

Unknown

A Pilot Study to Evaluate the Effect of Forsteo (Teriparatide, 1-34-rh-PTH) in Anorexia Nervosa Patients With Low Bone Mineral Density and Increased Bone Fagility (FAN-Trial)

Low Bone Mass in Anorexia Nervosa Patients

Switzerland
Novo Nordisk A/S

Completed

Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury

Trauma | Acquired Bleeding Disorder

India, Spain, Canada, Finland, Germany, Israel, Italy, Netherlands, Singapore, Switzerland, Taiwan
University of Bern
University of Zurich; University Hospital Inselspital, Berne

Suspended

Neural Response to Catecholamine Depletion in Subjects Suffering From Bulimia Nervosa in Their Past and Healthy Controls

Bulimia Nervosa | Eating Disorders | Dopamine | Reward | Catechol-O-methyltransferase

Switzerland
University of Zurich
Schweizerischer Nationalfonds

Completed

The Effects of Dietary Intervention on Gastrointestinal Function in Patients With Anorexia Nervosa and Obesity

Obesity | Anorexia Nervosa | Healthy Participants

Switzerland
University Hospital, Basel, Switzerland

Completed

Acquired Von Willebrand Syndrome in Severe Aortic Stenosis

Bleeding | Aortic Stenosis | Von Willebrand Disease

Switzerland
Novo Nordisk A/S

Completed

Evaluation of Recombinant Factor XIII for Prevention of Bleeding in Patients With FXIII Inherited Deficiency

Congenital Bleeding Disorder | Congenital FXIII Deficiency

United States, Israel, Austria, Spain, Switzerland, Germany, Canada, France, United Kingdom, Italy, Finland
Biosensors Europe SA
European Cardiovascular Research Center

Unknown

A Randomized Clinical Evaluation of the BioFreedom™ Stent (Leaders Free)

Bleeding | Stable Angina | In-stent Coronary Artery Restenosis | Ischemic Heart Disease Silent | ST Elevation (STEMI) and Non-ST Elevation (NSTEMI) Myocardial Infarction

Switzerland
Novo Nordisk A/S

Completed

A Trial Comparing Nonacog Beta Pegol (N9-GP) and ALPROLIX® in Patients With Haemophilia B (paradigm™7)

Congenital Bleeding Disorder | Haemophilia B

United States, Switzerland, Germany
Novo Nordisk A/S

Completed

Recombinant Factor VIIa in Acute Intracerebral Haemorrhage

Acquired Bleeding Disorder | Intracerebral Haemorrhage

Spain, Sweden, Singapore, Norway, Italy, Switzerland, Australia, Austria, Belgium, Canada, Denmark, Finland, Germany, Netherlands, United Kingdom
Dr. med. Carlo Cereda

Active, not recruiting

PRECISE (PERFUSION IMAGING TO IDENTIFY POSTERIOR CIRCULATION CANDIDATES FOR THROMBECTOMY) (SWISS-PRECISE)

Posterior Circulation Acute Ischemic Stroke Due to Large Vessel Occlusion of the Vertebral or Basilar Artery Needing Endovascular Thrombectomy

Switzerland
Drahomir Aujesky
Bayer; The Ottawa Hospital; University of Bern; Leiden University Medical Center; Schweizerischer Nationalfonds

Recruiting

Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism (SAFE-SSPE)

Cardiovascular Diseases | Respiratory Tract Diseases | Lung Diseases | Embolism | Embolism and Thrombosis | Bleeding | Venous Thromboembolism | Pulmonary Embolism | Anticoagulant-induced Bleeding

Netherlands, Switzerland, Belgium, France, Canada
Biotest
PRA Health Sciences

Completed

Adjusted Fibrinogen Replacement Strategy (AdFIrst)

Bleeding Disorder | Hypofibrinogenemia; Acquired

Belgium, Czechia, Germany, Poland, Spain, Switzerland, United Kingdom
Novo Nordisk A/S

Completed

Observational Registry of the Treatment of Glanzmann's Thrombasthenia

Congenital Bleeding Disorder | Glanzmann's Disease

Spain, Bulgaria, Pakistan, Belgium, Germany, France, United Kingdom, Italy, Hungary, Netherlands, United States, Algeria, Austria, Sweden, Switzerland
Novo Nordisk A/S

Completed

Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B (Explorer 1)

Healthy | Congenital Bleeding Disorder | Haemophilia A | Haemophilia B

Austria, Sweden, Spain, Switzerland, United Kingdom, Germany, Malaysia, Denmark, South Africa, Thailand, Italy
Novo Nordisk A/S

Completed

Safety and Pharmacokinetics of NNC 0129-0000-1003 in Subjects With Haemophilia A (pathfinder™1)

Congenital Bleeding Disorder | Haemophilia A

United States, Germany, Switzerland, United Kingdom, Italy, Japan, Turkey
ECRI bv
University of Bern; European Cardiovascular Research Center; Terumo Medical Corporation and other collaborators

Completed

Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Prolonged DAPT Regimen (MASTER DAPT)

Coronary Artery Disease | PCI | High Bleeding Risk

Netherlands, France, United Kingdom, Australia, Singapore, Japan, Italy, Poland, Spain, Switzerland, Israel, Argentina, Austria, Bahrain, Bangladesh, Belgium, Bulgaria, Czechia, Denmark, Estonia, Germany, Hungary, India, Korea, Republic... and more
Novo Nordisk A/S

Completed

Safety and Efficacy of Turoctocog Alfa (N8) in Prevention and On-demand Treatment of Bleeding Episodes in Subjects With Haemophilia A: An Extension to Trials NN7008-3543, NN7008-3545, NN7008-3600, NN7008-3893 and NN7008-4015

Congenital Bleeding Disorder | Haemophilia A

United States, Spain, Germany, Switzerland, Macedonia, The Former Yugoslav Republic of, Serbia, Taiwan, United Kingdom, Croatia, Italy, Malaysia, Brazil, Israel, Russian Federation, Turkey, Lithuania, Poland, Japan, Latvia, Puerto...
Novo Nordisk A/S

Completed

Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects (guardian™1)

Congenital Bleeding Disorder | Haemophilia A

United States, Spain, Germany, Switzerland, Serbia, Taiwan, United Kingdom, Croatia, Italy, Malaysia, Brazil, Japan, Denmark, Hungary, Israel, Turkey, Russian Federation, Former Serbia and Montenegro
Dr. Morten Hylander Møller
Rigshospitalet, Denmark; Copenhagen Trial Unit, Center for Clinical Intervention...

Completed

Stress Ulcer Prophylaxis in the Intensive Care Unit (SUP-ICU)

Gastrointestinal Bleeding | Stress Ulcers

Denmark, Netherlands, Switzerland, Norway, Finland, United Kingdom
Novo Nordisk A/S

Completed

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A (pathfinder™2)

Congenital Bleeding Disorder | Haemophilia A

France, United States, Denmark, Netherlands, Sweden, Spain, Germany, Switzerland, Taiwan, Japan, United Kingdom, Croatia, Italy, Malaysia, Brazil, Australia, Hungary, Israel, Turkey, Puerto Rico, Norway, Korea, Republic of, Bulgaria, Russian...
Cardiovascular Center Frankfurt

Completed

Peri-device Leakage Closure After LAAO

Stroke | Atrial Fibrillation | Bleeding | Leakage of Cardiac Device

Denmark, United States, Spain, Switzerland, Germany, Poland, United Kingdom
Novo Nordisk A/S

Completed

PROPACT: Retrospective Prophylaxis Patient Case Collection (PROPACT)

Congenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With Inhibitors

Slovakia, Spain, Argentina, Germany, Croatia, Italy, Canada, United Kingdom, Ireland, Sweden, France, United States, Czech Republic, Switzerland
Novo Nordisk A/S

Completed

Safety of Monthly Recombinant Factor XIII Replacement Therapy in Subjects With Congenital Factor XIII Deficiency: An Extension to Trial F13CD-1725 (mentor™2)

Congenital Bleeding Disorder | Congenital FXIII Deficiency

France, United States, Israel, Spain, Switzerland, Germany, Canada, Japan, United Kingdom, Italy, Finland, Austria
Novo Nordisk A/S

Completed

Safety and Efficacy of Turoctocog Alfa During Long-Term Treatment of Severe and Moderately Severe Haemophilia A (guardian™ 5)

Congenital Bleeding Disorder | Haemophilia A

Italy, Sweden, Netherlands, Austria, Spain, United States, Switzerland, Germany, France, Hungary, Greece, Slovenia, Czechia, Slovakia, Poland
Novo Nordisk A/S

Completed

A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A (pathfinder™5)

Congenital Bleeding Disorder | Haemophilia A

France, United States, Switzerland, Malaysia, Brazil, Canada, Japan, United Kingdom, Israel, Portugal, Ukraine, Greece, Lithuania, Puerto Rico, Turkey, Italy

Clinical Trials on Postcoital Bleeding in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations